EBS Emergent BioSolutions
- 6.170
- +0.130+2.15%
- 6.100
- -0.070-1.13%
Emergent BioSolutions News
Emergent BioSolutions(EBS.US) Director Sells US$61,100 in Common Stock
$Emergent BioSolutions(EBS.US)$ Director Zoon Kathryn C sold 10,000 shares of common stock on Jun 4, 2024 at an average price of $6.11 for a total value of $61,100.Source: Announcement What is stateme
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersAnitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares incre
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersConcord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. Calidi Biotherapeutics (AME
Express News | NYSE Order Imbalance 72987.0 Shares on Buy Side
Emergent BioSolutions(EBS.US) Director Sells US$8,436.3 in Common Stock
$Emergent BioSolutions(EBS.US)$ Director Zoon Kathryn C sold 1,830 shares of common stock on May 29, 2024 at an average price of $4.61 for a total value of $8,436.3.Source: Announcement What is statem
Emergent BioSolutions Shareholders Vote on Strategic Amendments
Emergent BioSolutions(EBS.US) Director Sells US$6,294.42 in Common Stock
$Emergent BioSolutions(EBS.US)$ Director Zoon Kathryn C sold 1,089 shares of common stock on May 21, 2024 at an average price of $5.78 for a total value of $6,294.42.Source: Announcement What is state
Express News | NYSE Order Imbalance 65441.0 Shares on Buy Side
Express News | NYSE Order Imbalance 62295.0 Shares on Buy Side
Walgreens Launches Own Version of Overdose Reversal Drug Narcan
By Colin Kellaher Walgreens is launching its own brand of naloxone, the nasal spray used to reverse opioid overdoses, that is priced more than 20% below the name-brand Narcan product. The drugstore
Express News | NYSE Order Imbalance 85703.0 Shares on Buy Side
Stocks With More Than 10% Short Interest - Finviz Screener
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
GAITHERSBURG, Md., May 10, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that its 2024 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast
Looking Into Emergent BioSolutions's Recent Short Interest
Emergent BioSolutions's (NYSE:EBS) short percent of float has fallen 23.58% since its last report. The company recently reported that it has 5.89 million shares sold short, which is 13.77% of all regu
Express News | NYSE Order Imbalance 57250.0 Shares on Buy Side
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.Investors are constantly o
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
Emergent BioSolutions, Inc. (NYSE:EBS) shares surged higher Thursday after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.Th
Emergent BioSolutions EBS; Accuray ARAY Analyst
Express News | NYSE Order Imbalance 155860.0 Shares on Buy Side
Sector Update: Health Care
Health care stocks were easing late Thursday afternoon, with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.1%. The iShares Biotechnology ETF (IBB) r
Analysis
Price Target
No Data
